RxDoctor Payments Data

Gerald Giurato

Family Medicine · Jacksonville, FLNPI 1205837028

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.4% of the total across 157 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Novo Nordisk at 35.2% of the total. Reporting peaked in 2019 at $1,259 and has fallen 98.9% since, to $14 in 2022.

$2,226in general payments, 2019–2025

Across 157 payments — averaging $14.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$784
  • AstraZeneca$201
  • Amarin Pharma, Inc.$160
  • Sunovion Pharmaceuticals Inc.$142
  • GSK$136
  • Sanofi-aventis U.S. LLC$120
  • plus $684 from 16 others

What the payments were for

  • Speaking & faculty fees$161%
  • Food & beverage$2,19098%
  • Education$201%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,226 in reported general payments places this provider in the 75th percentile of 7,282 family medicine providers in Florida.

See all family medicine providers in Florida →

Other family medicine in Jacksonville

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →